SMA Solar raises 2026 EBITDA guidance to €205 million–€230 million

By Public Technologies
  • SMA Solar Technology raised its 2026 sales forecast to EUR 1.68 billion–EUR 1.73 billion, from EUR 1.63 billion–EUR 1.73 billion.
  • EBITDA guidance increased to EUR 205 million–EUR 230 million, from EUR 180 million–EUR 230 million.
  • Nine-month sales reached EUR 1.16 billion; EBITDA totaled EUR 146 million.
  • Order backlog rose to EUR 1.86 billion from EUR 1.28 billion a year earlier.
  • Fourth-quarter sales should remain high across both divisions; Home & Business Solutions EBIT should improve significantly year over year but remain negative.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SMA Solar Technology AG published the original content used to generate this news brief on November 12, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.